International Trade Business ALL ABOUT NEURAXPHARM About Neuraxpharm History Where we are Executive commitee Our commitment R&D Excellence Manufacturing International Trade Business Ethics and Compliance channel Neuraxpharm About Neuraxpharm International Trade Business Moving forward CNS health with partners worldwide We offer our fully-fledged FDF portfolio to partners around the globe, blending our strong heritage in mental health and the central nervous system with a wide offering in ten additional therapeutic areas. In particular, we devote our efforts to the development of value-added products with highly beneficial effects on the patients’ treatment. And we do it with an innate passion and perseverance to move health forward for our customers and patients across the globe. + 0 Partners worldwide + 0 Products launched 0 % Portfolio expansion by 2023 Forward with a broad portfolio Nervous System Antineoplastic & immunomodulating agents Alimentary tract and metabolism Genito urinary system ans sex hormones Musculo-skeletal system Blood & blood forming organs Systemic hormonal preparations Respiratory system Cardiovascular system Antiinfectives for systemic use Sensory organs Patents approved 78.9% Patents filed 12.8% Patents in develpment 8.3% Moving forward with a broad portfolio Our FDF portfolio comprises one of the broadest CNS offerings along with a complete range of most therapeutic areas. We offer more than 85 FDFs for 40 indications in more than 100 presentations and strengths. We also provide a wide range of nutritional supplements and vitamins. Moving forward with innovative and market-leading brands Offering value-added products is at our core. Our FDF portfolio includes a number of innovative presentations which improve patients’ treatments through easier dosing and better adherence. We also offer several renowned brands such as Buccolam® and Preventan® which are sound market-leaders in their segments. Forward across the globe As the international business unit of Neuraxpharm, we are continuously seeking new partners on a global level. We are now present in more than 35 countries and will be entering more than 10 new markets by 2022. Products launched Products to be launched by 2022 Moving forward in business: Our business models License & supply agreements: Out-licensing We out-license our products to 3rd parties on a worldwide level. Our portfolio covers CNS and most therapeutic areas, with more than 85 EU/US CTD dossiers. Distribution agreements If you are interested in distributing our products in your country, we also offer distribution agreements, both exclusive and non-exclusive. Flexible models We are open to discuss any other partnership model you are looking for. Just reach out! Moving forward with our partners Forty years in the pharmaceutical sector have enabled us to create decades-long relationships with our partners, reflecting our flexibility and strong customer orientation. We currently work with more than 100 partners on a European and worldwide level. Moving forward together: Here’s why Value-added products are our backbone We commit ourselves to improving patients’ health and lives. That’s why we offer value-added FDFs and market-leading brands that enhance their treatments. Our one-of-a-kind portfolio comprises CNS products along with a complete offering in most therapeutic areas. Highly-valued customer service Flexibility and customer orientation throughout the whole value chain are embedded in our culture. We deliver the API or FDF you are looking for, ensure highest quality through our own manufacturing facilities, offer a broad scope of presentations and always deliver on time. Global reach Our European heritage makes us experts in highly regulated markets and thus a solid partner to operate across the world. Our regulatory teams are behind our commercial activities to support the partners’ local registration procedures in the licensed territories. Ready to move forward? Please leave us a message and we promise to come back to you very quickly! CNS Portfolio Neuraxpharm About us Our commitment Executive committee Neuraxpharm Blog Support Contact us Ethics and Compliance Channel Neuraxpharm @ 2021 Cookies policy Privacy policy Legal disclaimer Join our mailing list Get the latest updates from the Neuraxpharm.